358 results on '"Farmer, Cristan"'
Search Results
2. Spindle chirp and other sleep oscillatory features in young children with autism
3. GM1 gangliosidosis type II: Results of a 10-year prospective study
4. Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study
5. NIH Toolbox Cognition Battery Feasibility in Individuals with Williams Syndrome
6. Making Research Possible: Barriers and Solutions for Those with ASD and ID
7. Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion
8. Elevated amyloid beta peptides and total tau in cerebrospinal fluid in individuals with Creatine transporter deficiency
9. Posterior superior temporal cortex connectivity is related to social communication in toddlers
10. Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration
11. The relationship between the HDRS insomnia items and polysomnographic (PSG) measures in individuals with treatment-resistant depression
12. Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental Disorders
13. Inclusion of individuals with low IQ in drug development for autism spectrum disorder
14. Extracting Latent Subdimensions of Social Communication: A Cross-Measure Factor Analysis
15. The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response
16. Utilization of the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure-Adult to Screen Healthy Volunteers for Research Studies
17. The contribution of platelets to peripheral BDNF elevation in children with autism spectrum disorder
18. Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
19. Talking about Death or Suicide: Prevalence and Clinical Correlates in Youth with Autism Spectrum Disorder in the Psychiatric Inpatient Setting
20. Disentangling the association of depression on the anti-fatigue effects of ketamine
21. Characterizing the course of suicidal ideation response to ketamine
22. Attainment and loss of early social‐communication skills across neurodevelopmental conditions in the Norwegian Mother, Father and Child Cohort Study.
23. Measurement Invariance in Intellectual and Developmental Disability Research.
24. Factor structure of the VABS-3 Comprehensive Parent/Caregiver form in autistic individuals: Poor fit of three-factor and unidimensional models.
25. Trajectories of cognitive development in toddlers with language delays
26. Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
27. Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales
28. Neurodevelopmental Characterization of Young Children Diagnosed with Niemann-Pick Disease, Type C1
29. Psychotropic Medication Research in Children and Adolescents: Empirical Findings and Ethical Implications
30. Long-Term Neuropsychological Outcomes from an Open-Label Phase I/IIa Trial of 2-Hydroxypropyl-β-Cyclodextrins (VTS-270) in Niemann-Pick Disease, Type C1
31. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant
32. Clinical Implications From the Treatment of Severe Childhood Aggression (TOSCA) Study: A Re-Analysis and Integration of Findings
33. Intravenous delivery of AAV9-GLB1 gene therapy for GM1 gangliosidosis: An interim analysis
34. Corrigendum to “Elevated amyloid beta peptides and total tau in cerebrospinal fluid in individuals with Creatine transporter deficiency”
35. Longitudinal outcomes of children with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS)
36. Randomized, Controlled Trial of Intravenous Immunoglobulin for Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
37. Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial
38. Measurement of Nonverbal IQ in Autism Spectrum Disorder: Scores in Young Adulthood Compared to Early Childhood
39. Aggression in Children with Autism Spectrum Disorders and a Clinic-Referred Comparison Group
40. Longitudinal Study of Symptom Severity and Language in Minimally Verbal Children with Autism
41. Describing Function in ASD: Using the DSM-5 and Other Methods to Improve Precision
42. Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
43. Risperidone Added to Parent Training and Stimulant Medication: Effects on Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder, Conduct Disorder, and Peer Aggression
44. P094: Clinical and MRI correlations in GM1 patients: Finding biomarkers to predict treatment response with gene therapy*
45. What Does Risperidone Add to Parent Training and Stimulant for Severe Aggression in Child Attention-Deficit/Hyperactivity Disorder?
46. Spindle activity in young children with autism, developmental delay, or typical development
47. Riluzole Serum Concentration in Pediatric Patients Treated for Obsessive-Compulsive Disorder
48. Disentangling global and domain‐level adaptive behavior trajectories among children with autism spectrum disorder.
49. Examining the factor structure of the DSM‐5 Level 1 cross‐cutting symptom measure.
50. Characterization of autism spectrum disorder and neurodevelopmental profiles in youth with XYY syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.